AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Stoke Therapeutics, Inc. Director's Dealing 2021

Jan 27, 2021

32172_dirs_2021-01-27_51b0a27f-6ce2-4937-a6e9-6e78303f89e5.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Stoke Therapeutics, Inc. (STOK)
CIK: 0001623526
Period of Report: 2020-08-13

Reporting Person: Menzel Garry E (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities beneficially held	0	Direct